Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu | (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats:
- Alabama Drug Discovery Alliance
- Biochemistry and Molecular Genetics
- Biomatrix Engineering and Regenerative Medicine
- Cell biology
- Center for Biophysical Sciences and Engineering
- CCTS
- Center for Metabolic Bone Disease
- Microbiology
- Neurobiology
- Comprehensive Neuroscience Center
- Pathology, research shared with MS2
- Pharmacology and Toxicology
- Physiology and Biophysics
- UAB Research Foundation/IIE
- Research Administration
UAB Research Administration carefully invests to keep investigators competitive in an era of tight grant funding.
PhishMe is one of America’s fastest-growing private companies; Malcovery staff will remain at Birmingham’s Innovation Depot.
“A major issue facing biomedical research,” says Fran Lund, chair of UAB microbiology.
Validated biomarkers are crucial to developing effective treatments for this degenerative disease.
UAB researchers will enroll patients for prospective studies on pathogenesis of a potentially fatal blood clot disorder with a $2.5 million NIH grant.
Wrong shipment of mice led to estrogen breakthrough in trauma survival.
UAB's strengths in clinical care and research are powering an interdisciplinary expedition into largely uncharted territory: neuroinflammatory mechanisms in Parkinson's disease.
E. coli ClpB is a bacterial enzyme that untangles proteins. Such tangles are hallmarks of neurodegenerative diseases like Parkinson’s and Alzheimer’s. A study led by UAB's Aaron Lucius, Ph.D., offers new insight on this amazing molecular machine, and could eventually point toward new treatment approaches.
UAB researchers discover a new protein interaction from the 1918 flu strain that may help influenza circumvent the host immune response that would fight viral infection.
Famed neuroscientist Roger Nicoll, Ph.D., recently came to UAB to explain how he prevailed over great challenges in his life. Grad students in UAB’s Neuroscience Roadmap Scholars Program appreciated that, because they face challenges too. Learn about Nicoll’s tear-inducing speech, and the groundbreaking Roadmap program for underrepresented students, in The Mix.